A Phase I, Open-Label, study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese Participants
|Start Date:||October 2021|
|Primary Completion Date:
|Study Completion Date:
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Stay informed about new Trial Results Summaries with our email notification service
|CN|| Changchun, CN, 130021|
|CN|| Chengdu, CN, 610000|